如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)

替尔泊肽可降低肥胖或超重人群患 2 型糖尿病的预测风险:SURMOUNT-1 试验的事后分析

return icon返回

Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial

Author: Emily R. Hankosky PhD, Hui Wang PhD, Lisa M. Neff MD, Hong Kan PhD, Fangyu Wang MS, Nadia N. Ahmad MD, Adam Stefanski MD, W. Timothy Garvey MD
相关文献材料(78)

通过扫描二维码

体验礼来医学网小程序

通过扫描二维码

访问礼来中国医学官方微博

weibo iconmini iconsearch icon
return icon打开礼来医学网小程序